In:
Frontiers in Immunology, Frontiers Media SA, Vol. 11 ( 2020-11-20)
Abstract:
The disease course of COVID-19 in patients with immunodeficiencies is unclear, as well as the optimal therapeutic strategy. We report a case of a 37-year old male with common variable immunodeficiency disorder and a severe SARS-CoV-2 infection. After administration of convalescent plasma, the patient’s condition improved rapidly. Despite clinical recovery, viral RNA remained detectable up to 60 days after onset of symptoms. We propose that convalescent plasma might be considered as a treatment option in patients with CVID and severe COVID-19. In addition, in patients with immunodeficiencies, a different clinical course is possible, with prolonged viral shedding.
Type of Medium:
Online Resource
ISSN:
1664-3224
DOI:
10.3389/fimmu.2020.596761
DOI:
10.3389/fimmu.2020.596761.s001
DOI:
10.3389/fimmu.2020.596761.s002
DOI:
10.3389/fimmu.2020.596761.s003
DOI:
10.3389/fimmu.2020.596761.s004
Language:
Unknown
Publisher:
Frontiers Media SA
Publication Date:
2020
detail.hit.zdb_id:
2606827-8